218 related articles for article (PubMed ID: 20079871)
1. Research and development of universal influenza vaccines.
Du L; Zhou Y; Jiang S
Microbes Infect; 2010 Apr; 12(4):280-6. PubMed ID: 20079871
[TBL] [Abstract][Full Text] [Related]
2. Advancements in the development of subunit influenza vaccines.
Zhang N; Zheng BJ; Lu L; Zhou Y; Jiang S; Du L
Microbes Infect; 2015 Feb; 17(2):123-34. PubMed ID: 25529753
[TBL] [Abstract][Full Text] [Related]
3. [Universal influenza vaccines: developments, prospects for use].
Tsybalova LM; Kiselev OI
Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
[TBL] [Abstract][Full Text] [Related]
4. Pandemic preparedness: toward a universal influenza vaccine.
Roose K; Fiers W; Saelens X
Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
[TBL] [Abstract][Full Text] [Related]
5. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
6. Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice.
Subathra M; Santhakumar P; Satyam Naidu S; Lakshmi Narasu M; Senthilkumar TM; Lal SK
Appl Biochem Biotechnol; 2014 Apr; 172(7):3635-45. PubMed ID: 24562978
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus-like particle vaccines.
Haynes JR
Expert Rev Vaccines; 2009 Apr; 8(4):435-45. PubMed ID: 19348559
[TBL] [Abstract][Full Text] [Related]
8. Developments of subunit and VLP vaccines against influenza A virus.
Deng MP; Hu ZH; Wang HL; Deng F
Virol Sin; 2012 Jun; 27(3):145-53. PubMed ID: 22684468
[TBL] [Abstract][Full Text] [Related]
9. M2e-based universal influenza A vaccine.
Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
[TBL] [Abstract][Full Text] [Related]
10. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
11. M2e-based universal influenza vaccines: a historical overview and new approaches to development.
Mezhenskaya D; Isakova-Sivak I; Rudenko L
J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405
[TBL] [Abstract][Full Text] [Related]
12. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.
Schotsaert M; De Filette M; Fiers W; Saelens X
Expert Rev Vaccines; 2009 Apr; 8(4):499-508. PubMed ID: 19348565
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine: Where are we and where do we go?
Keshavarz M; Mirzaei H; Salemi M; Momeni F; Mousavi MJ; Sadeghalvad M; Arjeini Y; Solaymani-Mohammadi F; Sadri Nahand J; Namdari H; Mokhtari-Azad T; Rezaei F
Rev Med Virol; 2019 Jan; 29(1):e2014. PubMed ID: 30408280
[TBL] [Abstract][Full Text] [Related]
14. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
[TBL] [Abstract][Full Text] [Related]
15. [Research progress and prospect of universal influenza vaccine].
Luo DY; Xue CY; Cao YC
Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
[TBL] [Abstract][Full Text] [Related]
16. Universal influenza vaccine: the holy grail?
Shaw AR
Expert Rev Vaccines; 2012 Aug; 11(8):923-7. PubMed ID: 23002973
[TBL] [Abstract][Full Text] [Related]
17. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
[TBL] [Abstract][Full Text] [Related]
18. A "universal" human influenza A vaccine.
Fiers W; De Filette M; Birkett A; Neirynck S; Min Jou W
Virus Res; 2004 Jul; 103(1-2):173-6. PubMed ID: 15163506
[TBL] [Abstract][Full Text] [Related]
19. New technologies for influenza vaccines.
Dormitzer PR; Tsai TF; Del Giudice G
Hum Vaccin Immunother; 2012 Jan; 8(1):45-58. PubMed ID: 22251994
[TBL] [Abstract][Full Text] [Related]
20. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.
Zharikova D; Mozdzanowska K; Feng J; Zhang M; Gerhard W
J Virol; 2005 Jun; 79(11):6644-54. PubMed ID: 15890902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
